Illustrating the safety of a new drug treatment designed for spinal cord injury
New orally available drug for spinal cord injury found to be safe and tolerable in healthy participants New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has demonstrated the safety and tolerability of a new drug treatment designed as a therapeutic intervention for spinal cord injury (SCI). The research, … Read more